| First Author | Löffler MC | Year | 2018 |
| Journal | EMBO J | Volume | 37 |
| Issue | 22 | PubMed ID | 30389661 |
| Mgi Jnum | J:270453 | Mgi Id | MGI:6276384 |
| Doi | 10.15252/embj.201899182 | Citation | Loffler MC, et al. (2018) Protein kinase D1 deletion in adipocytes enhances energy dissipation and protects against adiposity. EMBO J 37(22) |
| abstractText | Nutrient overload in combination with decreased energy dissipation promotes obesity and diabetes. Obesity results in a hormonal imbalance, which among others activates G protein-coupled receptors utilizing diacylglycerol (DAG) as secondary messenger. Protein kinase D1 (PKD1) is a DAG effector, which integrates multiple nutritional and hormonal inputs, but its physiological role in adipocytes is unknown. Here, we show that PKD1 promotes lipogenesis and suppresses mitochondrial fragmentation, biogenesis, respiration, and energy dissipation in an AMP-activated protein kinase (AMPK)-dependent manner. Moreover, mice lacking PKD1 in adipocytes are resistant to diet-induced obesity due to elevated energy expenditure. Beiging of adipocytes promotes energy expenditure and counteracts obesity. Consistently, deletion of PKD1 promotes expression of the beta3-adrenergic receptor (ADRB3) in a CCAAT/enhancer binding protein (C/EBP)-alpha- and delta-dependent manner, which leads to the elevated expression of beige markers in adipocytes and subcutaneous adipose tissue. Finally, deletion of PKD1 in adipocytes improves insulin sensitivity and ameliorates liver steatosis. Thus, depletion of PKD1 in adipocytes increases energy dissipation by several complementary mechanisms and might represent an attractive strategy to treat obesity and its related complications. |
